TARS09302024 13G

Company

Tarsus Pharmaceuticals, Inc.

Filed

November 12, 2024

Accession Number

0000053417-24-000089

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →